As Buckeye Partners LP (BPL) Market Value Declined, Shareholder Cohen Capital Management Boosted Stake; Paratek Pharmaceuticals (PRTK) Shareholder Roumell Asset Management Trimmed Its Stake by $3.91 Million

February 23, 2018 - By Peter Erickson

Jim Roumell decreased its stake in Paratek Pharmaceuticals Inc (PRTK) by 60.66% based on its latest 2017Q3 regulatory filing with the SEC. Roumell Asset Management Llc sold 156,349 shares as the company’s stock rose 33.85% with the market. The hedge fund run by Jim Roumell held 101,399 shares of the health care company at the end of 2017Q3, valued at $2.55M, down from 257,748 at the end of the previous reported quarter. Roumell Asset Management Llc who had been investing in Paratek Pharmaceuticals Inc for a number of months, seems to be less bullish one the $410.48M market cap company. The stock decreased 2.22% or $0.3 during the last trading session, reaching $13.2. About 249,328 shares traded. Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) has risen 62.03% since February 23, 2017 and is uptrending. It has outperformed by 45.33% the S&P500.

Cohen Capital Management Inc increased its stake in Buckeye Partners Lp (BPL) by 10.49% based on its latest 2017Q3 regulatory filing with the SEC. Cohen Capital Management Inc bought 9,800 shares as the company’s stock declined 5.01% while stock markets rallied. The institutional investor held 103,184 shares of the natural gas distribution company at the end of 2017Q3, valued at $5.88 million, up from 93,384 at the end of the previous reported quarter. Cohen Capital Management Inc who had been investing in Buckeye Partners Lp for a number of months, seems to be bullish on the $6.77 billion market cap company. The stock decreased 4.09% or $1.97 during the last trading session, reaching $46.17. About 926,534 shares traded or 14.07% up from the average. Buckeye Partners, L.P. (NYSE:BPL) has declined 5.99% since February 23, 2017 and is downtrending. It has underperformed by 22.69% the S&P500.




Among 10 analysts covering Paratek Pharmaceuticals (NASDAQ:PRTK), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Paratek Pharmaceuticals had 24 analyst reports since July 23, 2015 according to SRatingsIntel. The stock has “Buy” rating by Gabelli on Thursday, July 23. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, August 23 report. The rating was reinitiated by Leerink Swann with “Outperform” on Thursday, October 27. The rating was maintained by H.C. Wainwright on Friday, June 17 with “Buy”. As per Tuesday, July 18, the company rating was maintained by H.C. Wainwright. The stock has “Buy” rating by Cantor Fitzgerald on Wednesday, November 8. Ladenburg Thalmann maintained Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) on Friday, June 17 with “Buy” rating. The firm earned “Buy” rating on Thursday, September 21 by Robert W. Baird. Zacks upgraded Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) on Tuesday, September 22 to “Hold” rating. Cantor Fitzgerald maintained Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) on Thursday, June 29 with “Buy” rating.

Analysts await Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) to report earnings on March, 1. They expect $-0.72 EPS, up 37.93% or $0.44 from last year’s $-1.16 per share. After $-0.77 actual EPS reported by Paratek Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -6.49% EPS growth.

Investors sentiment decreased to 1.54 in 2017 Q3. Its down 0.35, from 1.89 in 2017Q2. It fall, as 17 investors sold PRTK shares while 29 reduced holdings. 33 funds opened positions while 38 raised stakes. 20.11 million shares or 4.43% more from 19.26 million shares in 2017Q2 were reported. Moreover, Goldman Sachs Grp Inc has 0% invested in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Pictet Asset Management accumulated 661,995 shares. Numeric Invsts Limited Liability Company accumulated 233,120 shares. 24,522 are held by Cadence Capital Mgmt Lc. Deutsche Bankshares Ag has invested 0.01% in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Art Advsrs Limited Liability invested in 0.02% or 14,537 shares. Granite Point Cap Management Lp holds 0.14% in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) or 26,400 shares. Loeb Prns owns 9,000 shares. Schwab Charles Inv Incorporated has invested 0% of its portfolio in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Lpl Finance Lc accumulated 0% or 39,450 shares. Baupost Group Incorporated Ltd Company Ma reported 2.39M shares. Alyeska Grp LP reported 0.19% of its portfolio in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Fmr Ltd Limited Liability Company invested in 1.46M shares or 0% of the stock. Fortress Gru Ltd Liability Com accumulated 433,804 shares. The New York-based General American Invsts Inc has invested 0.83% in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK).

Roumell Asset Management Llc, which manages about $293.14M and $42.50 million US Long portfolio, upped its stake in Liquidity Services Inc (NASDAQ:LQDT) by 249,611 shares to 875,871 shares, valued at $5.17M in 2017Q3, according to the filing. It also increased its holding in Marchex Inc (NASDAQ:MCHX) by 245,220 shares in the quarter, for a total of 1.44M shares, and has risen its stake in Great Elm Cap Group Inc.

Cohen Capital Management Inc, which manages about $494.02M and $412.70M US Long portfolio, decreased its stake in Gaslog Ltd. (NYSE:GLOG) by 29,452 shares to 337,208 shares, valued at $5.88 million in 2017Q3, according to the filing.

Among 16 analysts covering Buckeye Partners (NYSE:BPL), 6 have Buy rating, 1 Sell and 9 Hold. Therefore 38% are positive. Buckeye Partners had 50 analyst reports since August 4, 2015 according to SRatingsIntel. On Thursday, August 25 the stock rating was initiated by Goldman Sachs with “Neutral”. The company was maintained on Monday, August 7 by RBC Capital Markets. The rating was initiated by DA Davidson with “Neutral” on Monday, November 16. The firm has “Neutral” rating given on Tuesday, March 15 by JP Morgan. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, July 13. The stock of Buckeye Partners, L.P. (NYSE:BPL) earned “Buy” rating by Citigroup on Tuesday, October 10. The company was maintained on Thursday, September 7 by Stifel Nicolaus. Stifel Nicolaus downgraded Buckeye Partners, L.P. (NYSE:BPL) rating on Monday, February 13. Stifel Nicolaus has “Hold” rating and $74 target. Barclays Capital reinitiated it with “Equal Weight” rating and $72 target in Tuesday, January 17 report. The company was upgraded on Monday, May 8 by Stifel Nicolaus.

Investors sentiment increased to 1 in 2017 Q3. Its up 0.03, from 0.97 in 2017Q2. It improved, as 39 investors sold BPL shares while 93 reduced holdings. 29 funds opened positions while 103 raised stakes. 96.89 million shares or 5.45% more from 91.89 million shares in 2017Q2 were reported. Advantus Cap Management has 0.02% invested in Buckeye Partners, L.P. (NYSE:BPL). Van Eck Associate Corp stated it has 18,341 shares or 0.01% of all its holdings. Peak6 Investments LP owns 0% invested in Buckeye Partners, L.P. (NYSE:BPL) for 16,141 shares. Cadence Management Limited Liability Com stated it has 0.53% of its portfolio in Buckeye Partners, L.P. (NYSE:BPL). Wesbanco Financial Bank stated it has 21,174 shares or 0.06% of all its holdings. Envestnet Asset Inc reported 2,586 shares stake. Bridges Counsel Inc, Nebraska-based fund reported 16,778 shares. Wealthtrust Axiom Ltd Llc accumulated 9,400 shares. 4,260 are held by Saratoga Invest. 3.48 million were accumulated by Center Coast Advsrs Limited Partnership. Tiedemann Wealth Mngmt Lc holds 0.03% or 95,606 shares. Spirit Of America Mgmt holds 1.33% in Buckeye Partners, L.P. (NYSE:BPL) or 220,715 shares. Oppenheimer & Company accumulated 5,250 shares or 0.01% of the stock. Bessemer Gp owns 1,008 shares. Oppenheimer Asset Mgmt Inc holds 0% or 2,692 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: